Austar Lifesciences (Austar Lifesciences) Interest Expense : $-2.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Austar Lifesciences's interest expense for the six months ended in Dec. 2023 was $ -1.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Austar Lifesciences's Operating Income for the six months ended in Dec. 2023 was $ 6.5 Mil. Austar Lifesciences's Interest Expense for the six months ended in Dec. 2023 was $ -1.0 Mil. Austar Lifesciences's Interest Coverage for the quarter that ended in Dec. 2023 was 6.61. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Austar Lifesciences Interest Expense Historical Data

The historical data trend for Austar Lifesciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Interest Expense Chart

Austar Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.48

-0.43

-0.69

-1.38

-1.96

Austar Lifesciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.42	-0.52	-0.88	-0.96	-0.99

Austar Lifesciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.0 Mil.

Austar Lifesciences (OTCPK:AULSF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Austar Lifesciences's Interest Expense for the six months ended in Dec. 2023 was $-1.0 Mil. Its Operating Income for the six months ended in Dec. 2023 was $6.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $22.8 Mil.

Austar Lifesciences's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	6.547	/	-0.99
	=	6.61

The higher the ratio, the stronger the company's financial strength is.

Austar Lifesciences (Austar Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

06118:Hong Kong

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines